[1] 陈伟伟, 高润霖, 刘力生, 等.《中国心血管病报告2016》概要[J].中国循环杂志, 2017, 32(06):521. doi: 10.3969/j.issn.1000-3614.2017.06.001
[2] GENSINI GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51(3):606. doi: 10.1016/S0002-9149(83)80105-2
[3] FUKUSHIMA Y, HIRAYAMA S, UENO T, et al.Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome[J].Clin Chim Acta, 2011, 412(15/16):1423.
[4] ORAVEC S, DUKAT A, GAVORNIK P, et al.Contribution of atherogenic lipoprotein profile to development of arterial hypertension[J].Bratisl Lek Listy, 2011, 112(1):4.
[5] NISHIKURA T, KOBA S, YOKOTA Y, et al.Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease[J].J Atheroscler Thromb, 2014, 21(8):755. doi: 10.5551/jat.23465
[6] BANSAL SK, YADAV R.A Study of the extended lipid profile including oxidized LDL, small dense LDL, lipoprotein(a) and apolipoproteins in the assessment of cardiovascular risk in hypothyroid patients[J].J Clin Diagn Res, 2016, 10(6):BC04.
[7] BARBALHO SM, TOFANO RJ, Bechara MD, et al.Castelli Index and estimative of LDL-c particle size may still help in the clinical practice[J].J Cardiovasc Dis Res, 2016, 7(2):86.
[8] TSAI MY, STEFFEN BT, GUAN W, et al.New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease:the Multi-ethnic Study of Atherosclerosis[J].Arterioscler Thromb Vasc Biol, 2014, 34(1):196. doi: 10.1161/ATVBAHA.113.302401
[9] 翟菊萍, 黄惠芳, 顾国浩, 等.小而密低密度脂蛋白与冠心病的相关性研究[J].中国现代医学杂志, 2011, 21(27):3376. doi: 10.3969/j.issn.1005-8982.2011.27.012
[10] 戴雯, 李艳.冠心病患者血清sd-LDL和hs-CRP与冠状动脉狭窄程度的相关性研究[J].海南医学, 2017, 28(7):1045. doi: 10.3969/j.issn.1003-6350.2017.07.005
[11] KOBA S, HIRANO T, KONDO T, et al.Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease[J].Am Heart J, 2002, 144(6):1026. doi: 10.1067/mhj.2002.126119
[12] LEGRAND-POELS S, ESSER N, L'HOMME L, et al.Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes[J].Biochem Pharmacol, 2014, 92(1):131.
[13] MA P, HAN L, LV Z, et al.In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome[J].BMC Cardiovasc Disord, 2016, 16(1):29. doi: 10.1186/s12872-016-0199-1
[14] 刘畅, 王秋丽.血清HDL-C、SOD及游离脂肪酸水平与急性冠脉综合征的相关性[J].中国老年学杂志, 2015, 35(11):2975. doi: 10.3969/j.issn.1005-9202.2015.11.042
[15] GRUZDEVA O, UCHASOVA E, DYLEVA Y, et al.Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction[J].Lipids Health Dis, 2014, 13(1):111. doi: 10.1186/1476-511X-13-111
[16] HE LY, ZHAO JF, Han JL, et al.Correlation between serum free fatty acids levels and Gensini score in elderly patients with coronary heart disease[J].J Geriatr Cardiol, 2014, 11(1):57.
[17] 王白石, 李东阳, 陈兴国, 等.游离脂肪酸与冠心病患者冠脉病变严重程度的相关性[J].中国老年学杂志, 2017, 37(6):1352. doi: 10.3969/j.issn.1005-9202.2017.06.020